CELLINK to acquire single-cell printing company cytena for over €30M AM Industry
Bioprinting company CELLINK has announced it has entered into an agreement with life science company cytena GmbH to acquire all of the company’s shares for €30.25 million (roughly $33.87 million). The acquisition is expected to bolster CELLINK’s commercial strategy and strengthen its product offering.